We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWSA icon
601
News Corp Class A
NWSA
$15.4B
$898K 0.02%
+38,625
New +$914K
C icon
602
Citigroup
C
$227B
$883K 0.02%
12,582
+2,464
+24% +$172K
CVS icon
603
CALL
CVS Health
CVS
$121B
$883K 0.02%
10,400
EWBC icon
604
East-West Bancorp
EWBC
$18B
$883K 0.02%
11,383
+6,720
+144% +$489K
UHS icon
605
Universal Health Services
UHS
$10.5B
$883K 0.02%
+6,379
New +$966K
HON icon
606
Honeywell
HON
$77.2B
$879K 0.02%
4,393
-12,449
-74% -$2.65M
SYNH
607
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$876K 0.02%
10,016
-4,399
-31% -$398K
MOS icon
608
CALL
The Mosaic Company
MOS
$7.26B
$875K 0.02%
24,500
+7,000
+40% +$224K
PLD icon
609
Prologis
PLD
$131B
$874K 0.02%
6,971
-16,481
-70% -$2.14M
DGNU
610
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$873K 0.02%
+89,035
New +$879K
MDT icon
611
Medtronic
MDT
$114B
$871K 0.02%
6,945
+3,907
+129% +$506K
RH icon
612
PUT
RH
RH
$3.58B
$867K 0.02%
1,300
SGI
613
Somnigroup International
SGI
$13.4B
$867K 0.02%
18,690
-18,692
-50% -$817K
XLI icon
614
State Street Industrial Select Sector SPDR ETF
XLI
$34.5B
$865K 0.02%
+8,840
New +$908K
DAC icon
615
Danaos Corp
DAC
$2.54B
$860K 0.02%
10,500
+5,108
+95% +$387K
RDY icon
616
Dr. Reddy's Laboratories
RDY
$10.1B
$860K 0.02%
66,000
RXRA
617
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
$856K 0.02%
87,973
+7,273
+9% +$70.9K
HYZN
618
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$852K 0.02%
+2,454
New +$1.06M
INSW icon
619
International Seaways
INSW
$4.54B
$850K 0.02%
46,662
+30,262
+185% +$516K
CVS icon
620
PUT
CVS Health
CVS
$121B
$849K 0.02%
10,000
-8,000
-44% -$670K
CNBKA
621
DELISTED
Century Bancorp Inc/Mass
CNBKA
$849K 0.02%
+7,368
New +$843K
ZUO
622
DELISTED
Zuora, Inc.
ZUO
$848K 0.02%
51,173
+38
+0.1% +$640
ZNGA
623
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$848K 0.02%
112,680
+11,957
+12% +$109K
FYBR
624
DELISTED
Frontier Communications
FYBR
$847K 0.02%
30,401
-290,690
-91% -$8.65M
TNA icon
625
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.45B
$846K 0.02%
10,200

Similar funds

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.